Cancer Survivors Have Higher Rate of Antidepressant Use

Share this content:
Cancer Survivors Have Higher Rate of Antidepressant Use
Cancer Survivors Have Higher Rate of Antidepressant Use

THURSDAY, Oct. 27, 2016 (HealthDay News) -- Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those with no history of cancer, according to a study published online Oct. 26 in the Journal of Clinical Oncology.

Using data from the U.S. National Health Interview Survey for 2010 to 2013, Nikki Hawkins, Ph.D., a behavioral scientist at the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues analyzed 48,181 records to estimate the number of cancer survivors taking medication for anxiety or depression.

The researchers found that among 3,184 adult cancer survivors, 19.1 percent reported taking medication for anxiety, depression, or both. Among the 44,997 adults with no history of cancer, 10.4 percent reported use of these medications. Patients most likely to use antidepressants included those under 65, whites, individuals with public insurance and a usual source for medical care, and those with multiple chronic health conditions.

"Survivors might feel uneasy or stigmatized talking about the toll cancer takes on their emotions, but their psychological health is as important as their physical health and deserves the same level of attention," Hawkins told HealthDay. "We clearly have more work to do to better understand and treat the psychological and emotional burdens of cancer in addition to the physical effects of the disease."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »